Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.1.1.16EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.1.18EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.3.1 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.1.21EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.1.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.1.15.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.1.15.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.36 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.1.1.18EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.1.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.1.1.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.1.1.14EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.1.20EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.43.4 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.57 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.1.17EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.1.1.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.1.1.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.1.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.3.3 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.28.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.5.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.7.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.4.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.65EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.39.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XDQ.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.4.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.7.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.22EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.3.13EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XCUEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.27.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KB.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.14EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.32EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.1.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.51.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XDD.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.526 (Iota)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.2 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.621 (Mu)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.9.2 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.34 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.47 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
P.1.17 (Gamma)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.126 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used